alexa Abstract | HER2-Targeted Antibody Treatment for Ovarian Cancer Future Opportunities
ISSN: 2329-9053

Journal of Molecular Pharmaceutics & Organic Process Research
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Editorial Open Access

Abstract

There are an estimated 240,000 new cases of ovarian cancer diagnosed worldwide each year [1]. Due to late presentation, in many parts of the world it remains the most lethal gynecological cancer [2]. In 2004, a new model description of this disease was proposed that combined both histopathological and molecular features and which classified epithelial ovarian cancers into two broad categories designated Type I and Type II tumors [3].

To read the full article Peer-reviewed Article PDF image | Peer-reviewed Full Article image

Author(s): Simon P Langdon, Andrew H Sims

Keywords

Molecular and Cellular Biology, Protein Protein interactions

Share This Page

Additional Info

Loading
Loading Please wait..
 
 
 
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords